Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Second Quarter Fiscal 2014 Financial Results
2/7/2014 9:08:51 AM
MORRIS PLAINS, N.J., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that it will host a conference call and live audio webcast on Tuesday, February 11, 2014 at 10:00 a.m. Eastern Time to discuss financial results for the second quarter of fiscal year 2014, and review key clinical developments and future planned activities.
Help employers find you! Check out all the jobs and post your resume.
comments powered by